Data / Federal awards / NAICS 541715 / XEQUEL BIO, INC.
XEQUEL BIO, INC.: 2 federal contract awards, $-413,848 obligated (FY2024 to FY2027)
Updated October 6, 2026. Source: USAspending.gov.
XEQUEL BIO, INC. (UEI T4JKC8B27PJ7), Mount Pleasant, SC, received 2 federal prime contract awards with $-413,848 obligated in fiscal years 2024 to 2027, from 2 agencies under 2 NAICS codes. Its largest buyer is Department of Health and Human Services ($136,152) and its largest code is NAICS 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology).
The request: Every federal contract awarded under NAICS 541715, with the winner, the agency and the value. $10 of work on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every federal contract award on USAspending.gov and every open opportunity on SAM.gov, and this page is that reading. Ask for the awards in your niche and the winners, agencies, values and recompetes arrive in your sheet, CRM, Slack or agent as they are reported.
- UEI
- T4JKC8B27PJ7
- Location
- Mount Pleasant, SC
- Business size
- Small Business
- Contract awards
- 2
- Obligated
- $-413,848
- First action in window
- 2023-12-22
- Latest action
- 2026-08-20
Where the work is
NAICS codes, with the other winners in each.
| NAICS | Industry | Awards | Obligated |
|---|---|---|---|
| 541715 | Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) | 1 | $136,152 |
| 541711 | Research and Development in Biotechnology | 1 | $-550,000 |
Buying agencies
| Agency | Awards | Obligated |
|---|---|---|
| Department of Health and Human Services | 1 | $136,152 |
| Department of Defense | 1 | $-550,000 |
Obligations by fiscal year
| Fiscal year | Obligated |
|---|---|
| FY2024 | $137,994 |
| FY2025 | $-550,000 |
| FY2026 | $-1,842 |
Contract awards
All 2 awards in fiscal years 2024 to 2027.
| Award ID | Agency | Type | NAICS | What it buys | Obligated in window | Award value | Starts | Ends | Place of performance | Source |
|---|---|---|---|---|---|---|---|---|---|---|
| 75N93021C00009 | Department of Health and Human Services | Definitive Contract | 541715 | GRANEXIN AS A TOPICAL THERAPEUTIC TO MITIGATE CUTANEOUS RADIATION INJURY | $136,152 | $6,618,886 | March 16, 2021 | February 28, 2025 | Mount Pleasant, SC | usaspending.gov |
| W81XWH17C0065 | Department of Defense | Definitive Contract | 541711 | IGF::OT::IGF DHA SBIR PH II PROPOSAL NO. A2-6647 | $-550,000 | $999,960 | September 25, 2017 | September 27, 2022 | Mount Pleasant, SC | usaspending.gov |
Also on SpecStream
- All recipients under NAICS 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- All recipients under NAICS 541711 Research and Development in Biotechnology
- Open opportunities under NAICS 541715
Public U.S. federal spending data (U.S. Department of the Treasury). Obligations are the contract actions dated in fiscal years 2024 to 2027 of the USAspending.gov award archive of 2026-10-06; a contract's total value is its current value as USAspending reports it, including earlier years. Recipients are matched on their SAM.gov UEI, never on the name, and are shown as the government prints them. Sole proprietorships and opted-out entities count in the totals and are not named. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.